Case-control Study of the Risk Factors Linked to Respiratory Syncytial Virus Infection Requiring Hospitalization in Premature Infants Born at a Gestational Age of 33-35 Weeks in Spain
Overview
Affiliations
Background And Objective: The aim of this study was to identify those risk factors most likely to lead to the development of RSV-related respiratory Infection and subsequent hospital admission among premature infants born at 33-35 WGA (FLIP study)
Methods: This was a prospective case-control study. Cases (186) hospitalized for respiratory syncytial virus (RSV) illness were recruited from 50 participating Spanish hospitals during the 2002-2003 RSV season (October 2002-April 2003). Controls (371) were selected in June 2003 but born at same time as cases.
Results: Of these cases, 20.5% were admitted to the intensive care unit intensive care unit, and 7.6% required mechanical ventilation. None of the patients died. Conditional logistic regression analysis adjusted for medical center demonstrated that the risk of RSV-related respiratory infection requiring hospital admission in preterm infants 33-35 weeks of gestation (WGA) in Spain was most often associated with absolute chronologic age at start of RSV season < or =10 weeks [ie, born between July 15 and December 15; odds ratio (OR), 3.95; 95% confidence interval (CI), 2.65-5.90], breast-feeding for < or =2 months total (OR 3.26; 95% CI 1.96-5.42), presence of > or =1 school age siblings (OR 2.85; 95% CI 1.88-4.33), > or =4 residents and visitors at home (discounting school age siblings and the case/control him/herself) (OR 1.91; 95% CI 1.19-3.07) and a family history of wheezing (OR 1.90; 95% CI 1.19-3.01).
Conclusions: In premature infants born 33-35 WGA, certain underlying risk factors significantly increase the risk of RSV-related respiratory infection and hospitalization. Premature infants 33-35 WGA with additional risk factors should be considered for RSV prophylaxis with palivizumab.
Sheikh S, Sharif H, Sharif N Cureus. 2024; 16(2):e53378.
PMID: 38435208 PMC: 10907965. DOI: 10.7759/cureus.53378.
Paes B, Lanari M, Rodgers-Gray B, Fullarton J, Carbonell-Estrany X Front Pediatr. 2024; 12:1343960.
PMID: 38283631 PMC: 10811053. DOI: 10.3389/fped.2024.1343960.
Mineva G, Purtill H, Dunne C, Philip R BMJ Glob Health. 2023; 8(2).
PMID: 36746518 PMC: 9906265. DOI: 10.1136/bmjgh-2022-009693.
Quinn L, Shields M, Sinha I, Groves H Syst Rev. 2020; 9(1):269.
PMID: 33239107 PMC: 7690183. DOI: 10.1186/s13643-020-01527-y.
Respiratory Failure and Death in Vulnerable Premature Children With Lower Respiratory Tract Illness.
Ofman G, Pradarelli B, Caballero M, Bianchi A, Grimaldi L, Sancilio A J Infect Dis. 2020; 222(7):1129-1137.
PMID: 32006428 PMC: 7459133. DOI: 10.1093/infdis/jiaa046.